Fagron Completes Acquisition of Purifarma in Brazil

Fagron Completes Acquisition of University Compounding Pharmacy (UCP)

January 12, 2026

Healthcare Services

Fagron has completed its acquisition of University Compounding Pharmacy (UCP), a California-based 503A pharmaceutical compounder focused on the health and wellness segment. The deal, initially announced in September 2025, closed following customary clearance and reinforces Fagron’s strategy to build a nationwide U.S. compounding platform spanning both 503A and 503B services.

Fagron Completes Acquisition of University Compounding Pharmacy (UCP) in North America

January 12, 2026

Healthcare Services

Fagron has completed its acquisition of University Compounding Pharmacy (UCP), a 503A compounding pharmacy based in California and focused on health and wellness. The deal, announced in September 2025, strengthens Fagron’s U.S. footprint—particularly in California—and supports its strategy to build a nationwide platform spanning both 503A and 503B services.

Fagron Completes Acquisition of Purifarma

January 6, 2026

Healthcare Services

Fagron has announced the completion of its acquisition of Purifarma in Brazil, following CADE approval in October 2025. The company said the deal strengthens its scalable platform in essentials, with opportunities to improve the product mix, expand to industrial customers, and leverage purchasing advantages across Latin America.

PerkinElmer Acquires Project Farma

March 11, 2025

Healthcare Services

PerkinElmer announced the acquisition of Project Farma, a life sciences consultancy focused on advancing technical operations from ideation through commercialization. The deal expands PerkinElmer’s OneSource professional services offering for the life sciences value chain.

Adragos Pharma Acquires Baccinex

February 6, 2025

Pharmaceuticals

Adragos Pharma, a Munich-headquartered CDMO, has acquired Baccinex, a Swiss sterile fill-finish specialist based in Courroux, Jura. The acquisition adds a US FDA- and EU-GMP-certified 6,200 m² facility and over 110 sterile fill-finish experts to Adragos' global manufacturing network, enhancing its clinical and commercial sterile manufacturing capabilities.

AvevoRx Acquires Infupharma to Expand Specialty Infusion Presence in Florida

April 1, 2024

Healthcare Services

AvevoRx, an independent specialty infusion pharmacy provider headquartered in Greensboro, North Carolina, has acquired Hollywood, Florida–based Infupharma, Inc. (retail operations known as Global View Pharmacy), effective April 1, 2024. The deal gives AvevoRx its first presence in Florida, expanding geographic reach, payor access, and specialty infusion and compounding capabilities for patients in the state.